Drug Testing Advisory Board; Notice of Meeting, 66790-66791 [E6-19367]

Download as PDF 66790 Federal Register / Vol. 71, No. 221 / Thursday, November 16, 2006 / Notices Dated: November 7, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9209 Filed 11–15–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Child Health and Human Development; Notice of Closed Meetings pwalker on PROD1PC61 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Neural Tube Defects. Date: November 28, 2006. Time: 11 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Anne Krey, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, 301–435– 6908. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel Children Living in Rural Poverty: The Continuation of the Family Life Project. Date: November 30, 2006. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Jefferson, 2500 Calvert Street, NW., Washington, DC 20037. Contact Person: Marita R. Hopmann, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, 6100 Building, Room 5B01, Bethesda, MD 20892, (301) 435–6911, hopmannm@mail.nih.gov. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, A Prospective Study of Diet and Fibroids in Black Women. VerDate Aug<31>2005 20:27 Nov 15, 2006 Jkt 211001 Date: November 30, 2006. Time: 10 a.m. to 11 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Jon M. Ranhand, PhD, Scientist Review Administrator, Division of Scientific Review, National institute of Child Health and Human Development, NIH, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892, (301) 435–6884, ranhandj@mail.nih.gov. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel Environmental & Biological Variation and Language Growth. Date: December 5, 2006. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Jefferson Hotel, 1200 Sixteenth Street, NW., Washington, DC 20036. Contact Person: Marita R. Hopmann, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health, and Human Development, 6100 Building, Room 5B01, Bethesda, MD 20892, (301) 435–6911, hopmannm@mail.nih.gov. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel Translational Analyses of Chronic Aberrant Behavior Across the Life Span. Date: December 6, 2006. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Ave., NW., Washington, DC 20037. Contact Person: Marita R. Hopmann, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health, and Human Development, 6100 Building, Room 5B01, Bethesda, MD 20892, (301) 435–6911, hopmannm@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: November 7, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9210 Filed 11–15–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Drug Testing Advisory Board; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of the meeting of the Substance Abuse and Mental Health PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Services Administration (SAMHSA) Drug Testing Advisory Board in December 2006. A portion of the meeting will be open and will include, but not limited to, a Department of Health and Human Services drug testing program update, a Department of Transportation drug testing program update, a Nuclear Regulatory Commission drug testing program update, an update on the pilot performance testing programs for hair and oral fluid, results from a Medical Review Officer data source, and results from a study on the external contamination of hair with cocaine. Attendance by the public will be limited to space available. Public comments are welcome. Please communicate with Dr. Donna Bush, Executive Secretary (see contact information below), to make arrangements to comment or to request special accommodations for persons with disabilities. The Board will also meet to develop the final revisions to the proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs that were published in the Federal Register on April 13, 2004 (69 FR 19673). This meeting will be conducted in closed session since discussing these issues in open session will significantly frustrate the Department’s ability to develop the revisions to the Mandatory Guidelines. The HHS Office of General Counsel made the determination that such matters are protected by exemption 9(B) of section 552b(c) of title 5 U.S.C. and, therefore, may be closed to the public. To facilitate entering the building for the open session, public attendees are required to contact Mrs. Giselle Hersh, Division of Workplace Programs, 1 Choke Cherry Road, Room 2–1042, Rockville, MD 20857, 240–276–2605 (telephone) or by e-mail to Giselle.Hersh@samhsa.hhs.gov. Substantive program information and a roster of Board members may be obtained by contacting Dr. Bush or by accessing the SAMHSA workplace Web site (https://workplace.samhsa.gov). The transcript for the open session will be available on the SAMHSA workplace Web site within 3 weeks after the meeting. Committee Name: Substance Abuse and Mental Health Services Administration Drug Testing Advisory Board. Meeting Date: December 12–13, 2006. Place: SAMHSA Building, Rock Creek Room 1, Choke Cherry Road, Rockville, Maryland 20850. Type: Open: December 12, 2006; 8:30 a.m.–4:30 p.m. E:\FR\FM\16NON1.SGM 16NON1 Federal Register / Vol. 71, No. 221 / Thursday, November 16, 2006 / Notices Closed: December 13, 2006; 8:30 a.m.– Noon. Contact: Donna M. Bush, PhD, Executive Secretary, 1 Choke Cherry Road, Room 2–1033, Rockville, Maryland 20857, 240–276–2600 (telephone) and 240–276–2610 (fax). Email: Donna.Bush@samhsa.hhs.gov. November 8, 2006. Toian Vaughn, SAMHSA Committee Management Officer. [FR Doc. E6–19367 Filed 11–15–06; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [USCG–2006–26255] Use of Akers Breath Alcohol .02 Detection System Test Device for Serious Marine Incident Testing Coast Guard, DHS. ACTION: Notice. pwalker on PROD1PC61 with NOTICES AGENCY: SUMMARY: The Coast Guard announces that the use of a Breath Alcohol .02 Detection System manufactured by Akers Bioscience, Inc., may be used by the maritime industry to conduct alcohol tests in compliance with Coast Guard regulations. DATES: This notice is effective November 16, 2006. ADDRESSES: You may send questions regarding this notice to: Drug and Alcohol Program Manager, U.S. Coast Guard Headquarters, Room 2404 (G– PCA); 2100 Second St., SW., Washington, DC 20593–0001. FOR FURTHER INFORMATION CONTACT: If you have questions on this notice, call Robert C. Schoening, Drug and Alcohol Program Manager, G–PCA, Coast Guard, telephone 202–372–1033. If you have questions on viewing or submitting material to the docket, call Renee V. Wright, Program Manager, Docket Operations, telephone 202–493–0402. SUPPLEMENTARY INFORMATION: Privacy Act: Anyone can search the electronic form of all comments received into any of our dockets by the name of the individual submitting the comment (or signing the comment, if submitted on behalf of an association, business, labor union, etc.). You may review the Department of Transportation’s Privacy Act Statement in the Federal Register published on April 11, 2000 (65 FR 19477), or you may visit https://dms.dot.gov. Background and Purpose: The Coast Guard is making this announcement to VerDate Aug<31>2005 20:27 Nov 15, 2006 Jkt 211001 allow the use of the Akers Breath Alcohol .02 Detection System for use in the maritime industry. Akers Bioscience, Inc. has received a letter, dated October 6, 2006, from National Highway Traffic Safety Administration (NHTSA/DOT) that the Breath Alcohol .02 Detection System, has met the requirements of model specifications as required by NHTSA. In order to better serve the interests of the marine industry, Coast Guard is allowing the use of this device by marine employers until NHTSA publishes the next Conforming Products List for Alcohol Screen Devices (ASDs) in the Federal Register. This device will meet the requirements in 46 CFR Part 4. Further information on alcohol testing in the maritime industry following a serious marine incident, can be located in the Final rule published on December 22, 2005, in the Federal Register (70 FR 75954). Dated: November 8, 2006. B.M. Salerno, Rear Admiral, U.S. Coast Guard, Acting Assistant Commandant for Prevention. [FR Doc. E6–19317 Filed 11–15–06; 8:45 am] BILLING CODE 4910–15–P DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services Agency information Collection Activities: Extension of a Currently Approved Information Collection; Comment Request 60-Day Notice of Information Collection Under Review; Application for Permission to Reapply for Admission into the United States after Deportation or Removal; Form I–212. OMB Control Number 1615–0018. ACTION: The Department of Homeland Security, U.S. Citizenship and Immigration Services has submitted the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of 1995. The information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted for sixty days until January 16, 2007. Written comments and suggestions regarding items contained in this notice, and especially with regard to the estimated public burden and associated response time should be directed to the Department of Homeland Security (DHS), USCIS, Director, Regulatory Management Division, Clearance Office, PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 66791 111 Massachusetts Avenue, NW., Suite 3008, Washington, DC 20529. Comments may also be submitted to DHS via facsimile to 202–272–8352, or via e-mail at rfs.regs@dhs.gov. When submitting comments by e-mail add the OMB Control Number 1615–0018 in the subject box. Written comments and suggestions from the public and affected agencies concerning the collection of information should address one or more of the following four points: (1) Evaluate whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agencies estimate of the burden of the collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Extension of a currently approved information collection. (2) Title of the Form/Collection: Application for Permission to Reapply for Admission into the United States after Deportation or Removal. (3) Agency form number, if any, and the applicable component of the Department of Homeland Security sponsoring the collection: Form I–212. U.S. Citizenship and Immigration Services. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Individuals or households. The information furnished on Form I–212 will be used by USCIS to adjudicate applications filed by aliens requesting consent to reapply for admission to the United States after deportation, removal or departure, as provided under section 212 of the Immigration and Nationality Act. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: 4,200 responses at 2 hours per response. E:\FR\FM\16NON1.SGM 16NON1

Agencies

[Federal Register Volume 71, Number 221 (Thursday, November 16, 2006)]
[Notices]
[Pages 66790-66791]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-19367]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Drug Testing Advisory Board; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of the 
meeting of the Substance Abuse and Mental Health Services 
Administration (SAMHSA) Drug Testing Advisory Board in December 2006.
    A portion of the meeting will be open and will include, but not 
limited to, a Department of Health and Human Services drug testing 
program update, a Department of Transportation drug testing program 
update, a Nuclear Regulatory Commission drug testing program update, an 
update on the pilot performance testing programs for hair and oral 
fluid, results from a Medical Review Officer data source, and results 
from a study on the external contamination of hair with cocaine.
    Attendance by the public will be limited to space available. Public 
comments are welcome. Please communicate with Dr. Donna Bush, Executive 
Secretary (see contact information below), to make arrangements to 
comment or to request special accommodations for persons with 
disabilities.
    The Board will also meet to develop the final revisions to the 
proposed Mandatory Guidelines for Federal Workplace Drug Testing 
Programs that were published in the Federal Register on April 13, 2004 
(69 FR 19673). This meeting will be conducted in closed session since 
discussing these issues in open session will significantly frustrate 
the Department's ability to develop the revisions to the Mandatory 
Guidelines. The HHS Office of General Counsel made the determination 
that such matters are protected by exemption 9(B) of section 552b(c) of 
title 5 U.S.C. and, therefore, may be closed to the public.
    To facilitate entering the building for the open session, public 
attendees are required to contact Mrs. Giselle Hersh, Division of 
Workplace Programs, 1 Choke Cherry Road, Room 2-1042, Rockville, MD 
20857, 240-276-2605 (telephone) or by e-mail to 
Giselle.Hersh@samhsa.hhs.gov.
    Substantive program information and a roster of Board members may 
be obtained by contacting Dr. Bush or by accessing the SAMHSA workplace 
Web site (https://workplace.samhsa.gov). The transcript for the open 
session will be available on the SAMHSA workplace Web site within 3 
weeks after the meeting.
    Committee Name: Substance Abuse and Mental Health Services 
Administration Drug Testing Advisory Board.
    Meeting Date: December 12-13, 2006.
    Place: SAMHSA Building, Rock Creek Room 1, Choke Cherry Road, 
Rockville, Maryland 20850.
    Type: Open: December 12, 2006; 8:30 a.m.-4:30 p.m.

[[Page 66791]]

    Closed: December 13, 2006; 8:30 a.m.-Noon.
    Contact: Donna M. Bush, PhD, Executive Secretary, 1 Choke Cherry 
Road, Room 2-1033, Rockville, Maryland 20857, 240-276-2600 (telephone) 
and 240-276-2610 (fax). E-mail: Donna.Bush@samhsa.hhs.gov.

    November 8, 2006.
Toian Vaughn,
SAMHSA Committee Management Officer.
[FR Doc. E6-19367 Filed 11-15-06; 8:45 am]
BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.